Neoadjuvant Chemotherapy, Carboplatin, and Paclitaxel in Pregnancy of a 22-Year Old with Stage IIA2 Cervical Cancer

Background: Cervical cancer is the second most common cancer found in pregnant women at a young age. Neoadjuvant with carboplatin and paclitaxel is often given to patients with cervical cancer, but the experience of administration during pregnancy is very limited. Case: A 22-year-old woman was diagnosed with stage IIA2 cervical cancer at 26 weeks gestation. The patient received three medications, including neoadjuvant chemotherapy, carboplatin, and paclitaxel, in three cycles with three weeks intervals at 27 weeks gestation. The patient underwent pregnancy termination with emergency cesarean delivery at 36 weeks of gestation and continued with a hysterectomy radical for 60 days, after which the patient received a chemoradiation adjuvant. Mother and baby were found healthy at one year after the diagnosis. Conclusion: NACT inhibited progression of the disease and allowed fetal maturity in locally ad-vanced cervical cancer patient at a young age, followed by radical hysterectomy 60 weeks after cesarean section. The combination of carboplatin and paclitaxel seemed feasible and relatively safe for both the mother and the baby.